Viewing Study NCT03914261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:23 PM
Ignite Modification Date: 2026-05-20 @ 7:35 PM
Study NCT ID: NCT03914261
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2022-05-24
First Post: 2019-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Expanded Access to Risankizumab
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Crohn's Disease View
None Ulcerative Colitis (UC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Expanded Access View
None Pre-approval Access View
None Compassionate Use View
None Special Access Program View
None Named Patient Basis View
None Special Access Scheme View